New gel aims to zap persistent HPV in women
NCT ID NCT07601074
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This study tests whether a gel called DARE-HPV can clear a persistent high-risk HPV infection in the genital area. About 118 premenopausal women aged 22-50 with a long-lasting infection will receive one of two doses of the gel for 14 or 21 days, or a placebo. The main goal is to see if the virus is gone 3 months after treatment ends.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS (HPV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.